This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Histone deacetylase (HDAC) inhibitors are epigenetic modifiers which obstruct the removal of an acetyl groups from an ?-N-acetyl lysine on both histone or non-histone proteins. By altering gene expression, one result is cell cycle blockage at the G1 phase. Synthetic HDAC inhibitors are being tested for multiple biomedical applications including inhibition of tumor cell proliferation and the induction of immune tolerance. Unfortunately, histone deacetylase inhibitors efficacy has been limited by their short half-life in vivo. The goal of this proposed research is to increase the bioavailability of HDAC inhibitors in vivo by the derivization of Vorinostat? a class 1 HDAC inhibitor. We will start with Vorinostat, and attempt to modify it for increased stability and enhanced tumor targeting capacity. Although Vorinstat, has been approved as a treatment for cutaneous T-cell lymphoma, animal studies have found that this HDAC inhibitor breaks down within minutes thereby reducing its bioavailability. Structurally, Vorinostat maintains a carbon linker, and a hydrophobic cap, and a Zn2+-chelating hydroxamic acid. Although the hydroxamic acid is the functional region of Vorinostat its ability to be catalyzed under biological conditions decreases the half-life of Vorinostat in vivo. This project will synthesis and biologically evaluate novel N-hydroxy cyclic imides, N-alkyloxy esters, and polyethylene glycol (PEG)-linked Vorinstat derivatives designed for increased bioavailability by enhancing molecular stability of the hydroxamic acid and cellular targeting of Vorinostat derivatives. Targeting of the Vorinostat derivatives should allow for improved efficacy due to direct interaction with only the desired cancer cells. Structural confirmation and stability studies of the Vorinostat derivatives will use gas chromatography mass spectrometry (GCMS), infrared (IR), and nuclear magnetic resonance (NMR) spectroscopy. Two general protein assays (Apoptosis and Cell Proliferation Analysis) will be conducted for all Vorinostat derivatives in which EL4 cells (mouse T cell lymophoma) will determine specific biological activity using flow cytometry.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR016460-10
Application #
8359822
Study Section
Special Emphasis Panel (ZRR1-RI-7 (01))
Project Start
2011-05-01
Project End
2012-04-30
Budget Start
2011-05-01
Budget End
2012-04-30
Support Year
10
Fiscal Year
2011
Total Cost
$107,737
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Physiology
Type
Schools of Medicine
DUNS #
122452563
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Allison, Devin; Delancey, Evan; Ramey, Hunter et al. (2017) Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agents. Bioorg Med Chem Lett 27:387-392
MacNicol, Melanie C; Cragle, Chad E; McDaniel, F Kennedy et al. (2017) Evasion of regulatory phosphorylation by an alternatively spliced isoform of Musashi2. Sci Rep 7:11503
Gao, Bo; Li, Guojun; Liu, Juntao et al. (2017) Identification of driver modules in pan-cancer via coordinating coverage and exclusivity. Oncotarget 8:36115-36126
Rahmatallah, Yasir; Zybailov, Boris; Emmert-Streib, Frank et al. (2017) GSAR: Bioconductor package for Gene Set analysis in R. BMC Bioinformatics 18:61
Liu, Juntao; Li, Guojun; Chang, Zheng et al. (2016) BinPacker: Packing-Based De Novo Transcriptome Assembly from RNA-seq Data. PLoS Comput Biol 12:e1004772
Luo, Heng; Ye, Hao; Ng, Hui Wen et al. (2016) sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides. Sci Rep 6:32115
Yu, Alexander; Demirel, Doga; Halic, Tansel et al. (2016) Virtual Intraoperative Cholangiogram Using WebCL. Stud Health Technol Inform 220:459-64
Wang, Zhenjia; Li, Guojun; Robinson, Robert W et al. (2016) UniBic: Sequential row-based biclustering algorithm for analysis of gene expression data. Sci Rep 6:23466
Rahmatallah, Yasir; Emmert-Streib, Frank; Glazko, Galina (2016) Gene set analysis approaches for RNA-seq data: performance evaluation and application guideline. Brief Bioinform 17:393-407
Beckford, Floyd A; Brock, Alyssa; Gonzalez-SarrĂ­as, Antonio et al. (2016) Cytotoxic gallium complexes containing thiosemicarbazones derived from 9-anthraldehyde: Molecular docking with biomolecules. J Mol Struct 1121:156-166

Showing the most recent 10 out of 223 publications